Editorial: Closing in on the Role of Thymic Stromal Lymphopoietin Inhibition as a Therapeutic Entry Point for Systemic Sclerosis
DSpace/Manakin Repository
Editorial: Closing in on the Role of Thymic Stromal Lymphopoietin Inhibition as a Therapeutic Entry Point for Systemic Sclerosis
Affandi, Alsya J.; van Roon, Joel A.G.
(2016) Arthritis and Rheumatology, volume 68, issue 11, pp. 2571 - 2574
(Editorial)
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
Keywords: Immunology and Allergy, Rheumatology, Immunology
DOI:
https://doi.org/10.1002/art.39815
ISSN: 2326-5191
Publisher: John Wiley & Sons Inc.
(Peer reviewed)